Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Tuesday, November 3, 2026

Back to today

Stevanato down 30%. Yikes.

Stevanato fell 30% after forecasting low-single-digit 2027 growth as lower Nexa syringe volumes from a GLP-1 customer offset solid Q3 margins and non-GLP biologics demand.

STVN $5.4B
Best Anchor Stocks 3 clicks

From X

@calvinblissett 1 click

Calvin Blissett on X

@MBoquard Thanks Michel. My take on $ANGI Q3: The quarter was better than the stock implies. • Revenue $242M, -9% YoY (improved from -11% in Q2), in line with consensus • Adj. EBITDA $42.2M vs ~$29M expected, 17.4% margin • Proprietary service requests flat at 3.8M, revenue per lead +10%, Large Pro revenue +20%+ • EPS missed ($0.03 vs $0.11), but that's non-cash accelerated depreciation from retiring the legacy platform The balance sheet isn't the problem I made it out to be: • $202.5M cash vs $398.7M of 3.875% notes due Aug 2028, not within a year • $175M revolver undrawn to 2030 • Bought back ~$100M of bonds below par YTD ($8.4M gain) • ~$196M net debt, roughly 1.5x EBITDA • At $5.99: ~$246M mkt cap, ~$440M EV, ~2.6x Q3 run-rate EBITDA, ~3.4x trailing The real problem is supply, not demand: • Avg monthly active pros 101K, -14% • Monthly pro churn 6.7% vs 5.9% a year ago • Leads -18%, network service requests -33% (partly deliberate cuts to low-quality traffic) • 9M FCF -$7M vs +$34M last year. Operating cash flow $38M vs $93M of adj. EBITDA, with $45M of capex during the platform migration • The 300-role cut ($50-60M run-rate savings) comes with $18-30M of restructuring charges through 1H27 What the AlphaSense expert calls say: • Former Angi VP (Oct 12): recent declines are "primarily due to a shrinking base of service providers, not a loss of homeowner demand or LLM-driven disruption." • Former Angi GM (Sep 22): believes the business "has already hit its lowest point" and sees "limited downside risk from current levels." Blames a poorly executed rebrand for the lost organic traffic. • Former Angi Director of Product (Sep 21): bearish. Sees conversational AI as "an existential threat" that could bypass marketplaces entirely. • Nextdoor marketing lead (Oct 14): Google AI Overviews pose "a significant threat to Angi's organic traffic," and Thumbtack is outspending Angi on brand. • Former Angi VP of Finance (Oct 12): skeptical the international margins can be replicated in the US; integration and cost work is "far from complete." How I see it: If pros stabilize, capex drops now that the migration is done, and they keep retiring notes below par, I get to roughly $60-80M of FCF in 2027 on a ~$246M market cap. That's my estimate, not guidance. If churn keeps rising and AI starts showing up in proprietary service requests, the 17% margin is just cost cuts on a shrinking business. What I'm watching: tomorrow's call (new CEO Mike Steib, ~45 days in) and the Nov 17 investor day for 2027 targets, pro count, capex and what they do with the cash. Not investment advice.

Investor Letters

All letters

Initiation Report

Nine Mile Metals is initiated under research coverage.

VMSXF $15M
Atrium Research - Equity Research 1 click

When the liquidity does not add up

Arbor Realty Trust’s dividend suspension is presented as creating $60 million of liquidity, raising questions about its ability to meet…

ABR $2.2B
John Hempton's Newsletter 3 clicks

Verra veerer

Verra Mobility’s Avis termination threatens 2027 earnings, while Government Solutions profit rose 25% and implied fourth-quarter guidance…

VRRM $404M
The Oak Bloke 2 clicks
ADCT · long

Adc Therapeutics SA (adct)

ADC Therapeutics centers on ZYNLONTA, an approved CD19-directed antibody-drug conjugate, after shares rose from roughly $4.

ADCT $199M
Value Investors Club 3 clicks

Research Roundup Vol. LII

Dell’s AI-server demand and Microchip’s data-center components lead updates on Cirrus Logic and STMicroelectronics, alongside a weekly…

CRUS $5.6B
Monte Independent Investment Research 1 click

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 72 of 272

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

91 accounts
Nominate an account

Investor letters we follow

285 firms

Sectors

Ordered by how often our editor reaches for them.